Tscan Therapeutics Inc
General ticker "TCRX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $457.9M
Tscan Therapeutics Inc does not follow the US Stock Market performance with the rate: -13.1%.
Estimated limits based on current volatility of 4.4%: low 2.81$, high 3.07$
Factors to consider:
- Current price 14.5% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.52$, 7.93$]
- 2024-12-30 to 2025-12-30 estimated range: [3.16$, 7.21$]
Financial Metrics affecting the TCRX estimates:
- Negative: Non-GAAP EPS, $ of -1.89 <= 0.10
- Negative: Operating profit margin, % of -81.62 <= 1.03
- Negative: Operating cash flow per share per price, % of -14.03 <= 2.35
- Positive: -0.96 < Investing cash flow per share, $ of -0.93
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term TCRX quotes
Long-term TCRX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $10.14MM | $13.54MM | $21.05MM |
| Operating Expenses | $58.78MM | $80.17MM | $114.51MM |
| Operating Income | $-48.64MM | $-66.64MM | $-93.46MM |
| Non-Operating Income | $0.03MM | $0.83MM | $8.48MM |
| Interest Expense | $0.00MM | $1.18MM | $3.76MM |
| R&D Expense | $44.95MM | $59.82MM | $88.15MM |
| Income(Loss) | $-48.61MM | $-65.81MM | $-84.98MM |
| Profit(Loss) | $-48.61MM | $-65.81MM | $-84.98MM |
| Stockholders Equity | $160.78MM | $99.43MM | $150.87MM |
| Assets | $188.11MM | $199.09MM | $272.15MM |
| Operating Cash Flow | $-48.68MM | $-66.50MM | $-61.36MM |
| Capital expenditure | $9.94MM | $4.22MM | $3.15MM |
| Investing Cash Flow | $-9.94MM | $-4.22MM | $-60.76MM |
| Financing Cash Flow | $189.67MM | $29.36MM | $135.44MM |
| Earnings Per Share* | $-2.03 | $-2.74 | $-1.36 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.